Pfizer Accuses Expert Of Tainting Doctor Testimony

Law360, New York (September 18, 2009, 6:33 PM EDT) -- Pfizer Inc. is urging a federal court overseeing the multidistrict litigation over its alleged off-label promotion of epilepsy drug Neurontin to issue an order preventing plaintiffs’ counsel and their experts from allegedly trying to tamper with the testimony of plaintiffs’ doctors.

Pfizer and its Warner-Lambert Co. subsidiary filed an emergency motion in the U.S. District Court for the District of Massachusetts on Thursday, claiming a consultant for the plaintiffs sent a letter to at least one plaintiff’s psychiatrist that allegedly contained negative and misleading information about...
To view the full article, register now.




Case Information

Case Title

Harden Manufacturing Corporation v. Pfizer, Inc. et al

Case Number




Nature of Suit

Other Statutory Actions


Patti B. Saris

Date Filed

May 14, 2004

Law Firms


Government Agencies

Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.